Practicability and Acceptability of Stylomax® in Children

Usability and Acceptability of Stylomax® in Growth Hormone Deficient Children.

Primary objective:

to evaluate the practicability and acceptability of STYLOMAX®, a new injection device for MAXOMAT®, in children, for 1 year.

Inclusion Criteria:

• Children over 3 years of age with growth hormone deficiency, requiring treatment with MAXOMAT® according to the criteria of the MA.

Exclusion Criteria:

• The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.